Status: affected by circulating vaccine-derived poliovirus
Circulation of vaccine-derived poliovirus type 2 (cVDPV2) has been confirmed in Togo, related to a cVDPV2 affecting Jigawa, Nigeria.
Across the GPEI partnership, the outbreak preparedness and response task team (OPRTT) is working with our regional and country colleagues in supporting local public health authorities in carrying out a full field investigation and determining if there is a risk of local spread of this virus which might require a response.
Polio this week in Togo
- No case of circulating vaccine-derived poliovirus type 2 (cVDPV2) was reported this week. There is one cVDPV2 case in the country which is linked to Jigawa outbreak in Nigeria.
- Read our Togo country page for more information.
International Health Regulations
Countries affected by poliovirus transmission are subject to International Health Regulations Temporary Recommendations that request them to declare a case of polio as a national public health emergency and consideration vaccination of all international travellers, as per temporary recommendations issued as of September 2019.
WHO’s International Travel and Health recommends that all travellers to polio-affected areas be fully vaccinated against polio. Residents (and visitors for more than 4 weeks) from infected areas should receive an additional dose of OPV or inactivated polio vaccine (IPV) within 4 weeks to 12 months of travel.